| Financier | Commitments |
|---|---|
| IDA Credit | 23.60 |
| IDA Grant | 23.60 |
DRC COVID-19 Strategic Preparedness and Response Project (SPRP)
Abstract*
The proposed project will support the implementation of The Democratic Republic of Congo COVID-19 Preparedness and Response Plan endorsed by the Minister of Health (on March 16, 2020). It aims to: (i) strengthen technical and operational coordination of activities to prepare for and respond to COVID-19 through existing mechanisms and partnerships; (ii) develop and implement early detection of suspected cases of COVID-19 with or without epidemiological... Show More
Development Objective
The Program Development Objective is to prevent, detect and respond to the threat
posed by COVID-19, and strengthen national systems for public health preparedness.
Key Details
Project Details
P173825
Closed
Ghulam Sayed , Michel Lushimba, Meta Mobula
Democratic Republic of Congo
March 26, 2020
(as of board presentation)
April 2, 2020
June 23, 2020
US$ 47.20 million
Ministry of Health
2020
US$ 47.20 million
N/A
Substantial
June 30, 2024
No
BANK APPROVED
April 17, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 47.20 |
| IBRD + IDA Commitment | 47.20 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 47.20 |
Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Dec 26, 2023 | IDA-69620 | Loan Disb | 520,475.50 |
| Dec 26, 2023 | IDA-D8860 | Loan Disb | 520,475.50 |
| Dec 14, 2023 | IDA-D8860 | Loan Disb | -1,600,000.00 |
| Dec 18, 2023 | IDA-D8860 | Loan Disb | -2,392,903.80 |
| Dec 11, 2023 | IDA-69620 | Loan Disb | 6,790,963.50 |
| Dec 14, 2023 | IDA-69620 | Loan Disb | -1,600,000.00 |
| Dec 18, 2023 | IDA-69620 | Loan Disb | -2,392,903.80 |
| Dec 4, 2023 | IDA-D6020 | Loan Disb | 209,036.70 |
| Aug 15, 2024 | IDA-69620 | Int Charges | 9,845.49 |
| Aug 15, 2024 | IDA-69620 | Int Charges | 9,845.49 |
| Jun 10, 2024 | IDA-D8860 | Loan Disb | 2,256,013.80 |
| Oct 15, 2023 | IDA-66010 | Int Charges | 151,848.90 |
| Oct 15, 2023 | IDA-66010 | Int Charges | 151,848.90 |
| Aug 15, 2024 | IDA-69620 | Int Charges | 807,415.06 |
| Feb 17, 2023 | IDA-69620 | Loan Disb | 1,133,639.90 |
| Apr 25, 2023 | IDA-66010 | Int Charges | 151,765.47 |
| Apr 25, 2023 | IDA-66010 | Int Charges | 151,765.47 |
| Feb 15, 2023 | IDA-69620 | Int Charges | 156,046.19 |
| Feb 17, 2023 | IDA-D8860 | Loan Disb | 1,133,639.90 |
| Feb 15, 2023 | IDA-69620 | Int Charges | 156,046.19 |
| Feb 15, 2023 | IDA-69620 | Int Charges | 616,844.10 |
| Feb 15, 2023 | IDA-69620 | Int Charges | 616,844.10 |
| Aug 15, 2023 | IDA-69620 | Int Charges | 665,135.30 |
| Aug 15, 2023 | IDA-69620 | Int Charges | 665,135.30 |
| Aug 15, 2023 | IDA-69620 | Int Charges | 21,517.96 |
| Aug 15, 2023 | IDA-69620 | Int Charges | 21,517.96 |
| Jun 27, 2023 | IDA-D8860 | Loan Disb | 3,765,642.00 |
| Jun 30, 2023 | IDA-69620 | Loan Disb | 3,765,642.00 |
| Jun 26, 2023 | IDA-D8860 | Loan Disb | 2,252,250.00 |
| Jun 26, 2023 | IDA-69620 | Loan Disb | 2,712,924.50 |
| Jun 26, 2023 | IDA-69620 | Loan Disb | 2,252,250.00 |
| Nov 23, 2022 | IDA-66010 | Loan Disb | 60,791.60 |
| Sep 27, 2022 | IDA-D8860 | Loan Disb | 1,153,317.50 |
| Sep 27, 2022 | IDA-69620 | Loan Disb | 1,153,317.50 |
| Oct 15, 2022 | IDA-66010 | Int Charges | 31.00 |
| Oct 15, 2022 | IDA-66010 | Int Charges | 31.00 |
| Oct 15, 2022 | IDA-66010 | Int Charges | 148,538.52 |
| Oct 15, 2022 | IDA-66010 | Int Charges | 148,538.52 |
| Oct 21, 2022 | IDA-D8860 | Loan Disb | 18,607,338.00 |
| Oct 21, 2022 | IDA-69620 | Loan Disb | 18,607,338.00 |
| Jun 16, 2022 | IDA-69620 | Loan Disb | 2,738,971.00 |
| Jun 16, 2022 | IDA-69620 | Loan Disb | 21,692,328.00 |
| Jun 23, 2022 | IDA-69620 | Loan Disb | 7,500,000.00 |
| Jun 23, 2022 | IDA-69620 | Loan Disb | 3,288,029.00 |
| Jun 23, 2022 | IDA-69620 | Loan Disb | 14,880,348.00 |
| Jun 23, 2022 | IDA-69620 | Loan Disb | 484,267.00 |
| Apr 15, 2022 | IDA-66010 | Int Charges | 138,452.45 |
| Apr 15, 2022 | IDA-66010 | Int Charges | 2,523.26 |
| Apr 15, 2022 | IDA-66010 | Int Charges | 2,523.26 |
| Apr 15, 2022 | IDA-66010 | Int Charges | 138,452.45 |
| Apr 8, 2022 | IDA-66010 | Loan Disb | 122,610.85 |
| Jun 21, 2022 | IDA-D8860 | Loan Disb | 8,716,499.00 |
| Jun 21, 2022 | IDA-D8860 | Loan Disb | 600,600.00 |
| Jun 21, 2022 | IDA-D8860 | Loan Disb | 14,880,348.00 |
| Jun 21, 2022 | IDA-D8860 | Loan Disb | 3,288,029.00 |
| Jun 21, 2022 | IDA-D8860 | Loan Disb | 7,500,000.00 |
| Jun 21, 2022 | IDA-69620 | Loan Disb | 600,600.00 |
| Jun 21, 2022 | IDA-69620 | Loan Disb | 8,716,499.00 |
| Apr 11, 2022 | IDA-D6020 | Loan Disb | 219,318.00 |
| Feb 14, 2022 | IDA-66010 | Loan Disb | 400,895.20 |
| Jan 11, 2022 | IDA-66010 | Loan Disb | 424,513.56 |
| Jun 25, 2021 | IDA-66010 | Loan Disb | 402,036.00 |
| May 20, 2021 | IDA-66010 | Loan Disb | 2,559,884.00 |
| Apr 26, 2021 | IDA-66010 | Loan Disb | 1,297,161.00 |
| Sep 7, 2021 | IDA-66010 | Loan Disb | 633,813.00 |
| Aug 16, 2021 | IDA-66010 | Loan Disb | 76,281.60 |
| Oct 19, 2021 | IDA-66010 | Int Charges | 3,103.37 |
| Oct 19, 2021 | IDA-66010 | Int Charges | 3,103.37 |
| Oct 19, 2021 | IDA-66010 | Int Charges | 91,936.46 |
| Oct 19, 2021 | IDA-66010 | Int Charges | 91,936.46 |
| Sep 27, 2021 | IDA-66010 | Loan Disb | 2,293,851.00 |
| Jun 16, 2022 | IDA-D6020 | Loan Disb | 3,000,000.00 |
| Jun 16, 2022 | IDA-66010 | Loan Disb | 1,214,773.40 |
| May 19, 2022 | IDA-66010 | Loan Disb | 194,954.80 |
| Jun 16, 2022 | IDA-D8860 | Loan Disb | 21,692,328.00 |
| Jun 16, 2022 | IDA-D8860 | Loan Disb | 2,738,971.00 |
| Jun 23, 2022 | IDA-D8860 | Loan Disb | 484,267.00 |
| Mar 18, 2022 | IDA-D6020 | Loan Disb | 2,229,528.00 |
| Jun 29, 2021 | IDA-69620 | Loan Commitment | 100,000,000.00 |
| Jun 29, 2021 | IDA-D8860 | Loan Commitment | 100,000,000.00 |
| Aug 15, 2024 | IDA-69620 | Int Charges | 807,415.06 |
| Jun 10, 2024 | IDA-69620 | Loan Disb | 3,403,467.20 |
| Apr 16, 2024 | IDA-66010 | Int Charges | 151,848.90 |
| Apr 16, 2024 | IDA-66010 | Int Charges | 151,848.90 |
| Jun 4, 2024 | IDA-D8860 | Loan Disb | 202,072.00 |
| May 7, 2024 | IDA-D8860 | Loan Disb | 186,317.66 |
| May 7, 2024 | IDA-69620 | Loan Disb | 426,338.53 |
| Jun 4, 2024 | IDA-69620 | Loan Disb | 202,072.00 |
| Mar 1, 2024 | IDA-69620 | Loan Disb | 1,458,220.40 |
| Mar 1, 2024 | IDA-D6020 | Loan Disb | 400,000.00 |
| Mar 1, 2024 | IDA-66010 | Loan Disb | 238,632.66 |
| Mar 1, 2024 | IDA-D8860 | Loan Disb | 1,400,000.00 |
| Feb 15, 2024 | IDA-69620 | Int Charges | 19,490.86 |
| Feb 15, 2024 | IDA-69620 | Int Charges | 19,490.86 |
| Feb 15, 2024 | IDA-69620 | Int Charges | 771,650.60 |
| Feb 15, 2024 | IDA-69620 | Int Charges | 771,650.60 |
| May 28, 2024 | IDA-69620 | Loan Disb | 1,049,056.00 |
| Apr 24, 2024 | IDA-D8860 | Loan Disb | -23,690.72 |
| May 20, 2024 | IDA-D8860 | Loan Disb | 1,049,056.00 |
| Jun 28, 2024 | IDA-D8860 | Loan Disb | 709,507.44 |
| Apr 24, 2024 | IDA-69620 | Loan Disb | -23,690.70 |
| May 7, 2024 | IDA-D6020 | Loan Disb | 158,899.39 |
| Apr 2, 2020 | IDA-66010 | Loan Commitment | 23,600,000.00 |
| Apr 2, 2020 | IDA-D6020 | Loan Commitment | 23,600,000.00 |
| Jun 26, 2023 | IDA-D8860 | Loan Disb | 1,542,363.50 |
| Jun 30, 2020 | IDA-D6020 | Loan Disb | 1,982,171.60 |
| Jun 30, 2020 | IDA-D6020 | Loan Disb | 2,000,000.00 |
| Nov 2, 2020 | IDA-66010 | Loan Disb | 2,278,560.00 |
| Nov 2, 2020 | IDA-D6020 | Loan Disb | 1,792,407.60 |
| Sep 25, 2020 | IDA-D6020 | Loan Disb | 378,900.00 |
| Mar 10, 2021 | IDA-66010 | Loan Disb | 144,129.00 |
| Mar 10, 2021 | IDA-66010 | Loan Disb | 1,112,964.00 |
| Dec 7, 2020 | IDA-D6020 | Loan Disb | 1,657,347.00 |
| Mar 23, 2021 | IDA-D6020 | Loan Disb | 657,955.00 |
| Apr 14, 2021 | IDA-66010 | Loan Disb | 983,079.00 |
| May 11, 2021 | IDA-D6020 | Loan Disb | 2,483,760.00 |
| May 18, 2021 | IDA-D6020 | Loan Disb | 1,018,275.94 |
| Apr 15, 2021 | IDA-66010 | Loan Disb | 748,872.00 |
| Jun 21, 2021 | IDA-66010 | Loan Disb | 458,164.80 |
| Jun 21, 2021 | IDA-66010 | Loan Disb | 319,236.00 |
| Jun 30, 2021 | IDA-66010 | Loan Disb | 50,854.40 |
| Mar 29, 2021 | IDA-66010 | Loan Disb | 2,559,884.00 |
| Jul 28, 2021 | IDA-D6020 | Loan Disb | 5,375,682.50 |
| Jul 28, 2021 | IDA-66010 | Loan Disb | 3,934,775.00 |
| Jul 30, 2021 | IDA-66010 | Loan Disb | 687,247.20 |
| Jun 1, 2021 | IDA-66010 | Loan Disb | 402,036.00 |
| May 7, 2021 | IDA-66010 | Int Charges | 13,411.86 |
| May 7, 2021 | IDA-66010 | Int Charges | 13,411.86 |
| Jun 7, 2021 | IDA-D6020 | Loan Disb | 479,236.06 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Monitoring and Evaluation | Satisfactory | 2024-12-05 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-12-05 |
| Progress towards achievement of PDO | Satisfactory | 2024-12-05 |
| Procurement | Satisfactory | 2024-12-05 |
| Project Management | Satisfactory | 2024-12-05 |
| Financial Management | Moderately Satisfactory | 2024-12-05 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of targeted provinces with pandemic preparedness and response plans per Ministry of Health Guidelines Value 0.00 100.00 100.00 Date March 5, 2020 April 5, 2024 June 30, 2024 Comment Number of frontline health workers trained in infection prevention control per MoPHHP-approved protocols in targeted provinces Value 0.00 1034.00 1000.00 Date March 5, 2020 April 5, 2024 June 30, 2024 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan [by gender]), with a target of 25%. Value 0.00 34.50 25.00 Date March 5, 2021 January 31, 2024 June 30, 2024 Comment Percentage of those vaccinated who are female Value 0.00 41.00 50.00 Date March 5, 2021 April 5, 2024 June 30, 2024 Comment Percentage of target health centers with isolation and triage capacity for COVID-19 patients Value 0.00 80.00 100.00 Date March 5, 2020 April 5, 2024 June 30, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of specimens submitted for COVID-19 virus laboratory testing with results available within 48 hours Value 0.00 100.00 50.00 Date March 5, 2020 April 5, 2024 June 28, 2024 Comment Percentage of population able to identify three key symptoms of COVID-19 and three personal prevention measures Value 0.00 67.20 50.00 Date March 5, 2020 April 5, 2024 June 28, 2024 Comment National Deployment and Vaccination Plan (NDVP) for COVID-19 vaccines validated Value No Yes Yes Date March 5, 2021 April 5, 2024 June 28, 2024 Comment Number of targeted health facilities equipped with improved handwashing facilities Value 0.00 46.00 40.00 Date March 5, 2020 April 5, 2024 June 28, 2024 Comment Number of medical oxygen production units delivered to target facilities Value 0.00 11.00 8.00 Date March 5, 2020 April 5, 2024 June 28, 2024 Comment Number of target health facilities equipped with key equipment for oxygen therapy and monitoring of moderate and severe COVID-19 Value 0.00 59.00 40.00 Date March 5, 2020 April 5, 2024 June 28, 2024 Comment Percentage of health facilities designated as vaccination sites in project areas having adequate and functioning cold chain equipment maintaining temperature required for the COVID-19 vaccine assigned Value 0.00 73.70 80.00 Date March 5, 2021 April 5, 2024 June 28, 2024 Comment Establishment of monitoring and evaluation system for COVID-19 Value No Yes Yes Date March 5, 2020 April 5, 2024 June 30, 2022 Comment Percentage of complaints to the GRM that receive a response from the project within 4 weeks of initial complaint being recorded. Value 0.00 73.20 80.00 Date March 5, 2020 April 5, 2024 June 28, 2024 Comment National COVID-19 risk communication and community engagement strategy established Value No Yes Yes Date March 5, 2020 April 5, 2024 June 28, 2024 Comment Number of COVID-19 response reports prepared by the government on project implementation Value 0.00 4.00 4.00 Date March 5, 2020 April 5, 2024 June 28, 2024 Comment National risk communication and community engagement plan developed to reduce COVID-19 transmission and vaccine hesitancy Value No Yes Yes Date March 5, 2021 April 5, 2024 June 28, 2024 Comment Activation of the public health Emergency Operations Centre for COVID-19 Value No Yes Yes Date March 5, 2020 April 5, 2024 June 28, 2024 Comment Number of female community health workers (ReCOs) trained to provide accurate information about COVID-19 vaccines Value 0.00 169071.00 5000.00 Date March 5, 2021 April 5, 2024 June 28, 2024 Comment